Top 10 Levetiracetam (Keppra) Generic Manufacturers in India

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The demand for generic pharmaceuticals has been steadily increasing in India, with a focus on cost-effective alternatives to brand-name medications. Levetiracetam, commonly known by its brand name Keppra, is a widely used antiepileptic drug. In India, there is a growing market for generic manufacturers of Levetiracetam, with several companies competing for market share. According to recent statistics, the production volume of Levetiracetam generics in India has been on the rise, reflecting the growing demand for affordable epilepsy treatment options.

Top 10 Levetiracetam (Keppra) Generic Manufacturers in India:

1. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. is one of the largest generic pharmaceutical companies in India, with a strong presence in the Levetiracetam market. The company has a significant market share and produces a high volume of Levetiracetam generics.

2. Cipla Ltd.
Cipla Ltd. is another leading player in the Indian pharmaceutical industry, known for its high-quality generic medications, including Levetiracetam. The company’s Levetiracetam generics have gained popularity for their effectiveness and affordability.

3. Lupin Limited
Lupin Limited is a well-established pharmaceutical company in India, with a diverse portfolio of generic medications. The company’s Levetiracetam generics have been performing well in the market, contributing to Lupin’s overall success.

4. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd. is a key player in the Indian pharmaceutical market, known for its innovative generic formulations. The company’s Levetiracetam generics have been in high demand, reflecting the company’s commitment to providing quality medications at competitive prices.

5. Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. is a prominent player in the Indian pharmaceutical industry, specializing in generic medications. The company’s Levetiracetam generics have been well-received by healthcare professionals and patients alike, contributing to Aurobindo Pharma’s market presence.

6. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd. is a leading pharmaceutical company in India, with a strong focus on generic medications. The company’s Levetiracetam generics have been gaining traction in the market, driving growth for Torrent Pharmaceuticals.

7. Intas Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd. is known for its wide range of generic medications, including Levetiracetam. The company’s Levetiracetam generics have been performing well in the market, reflecting Intas Pharmaceuticals’ commitment to quality and affordability.

8. Zydus Cadila
Zydus Cadila is a well-known pharmaceutical company in India, with a strong presence in the generic medication market. The company’s Levetiracetam generics have been gaining popularity among healthcare providers and patients, contributing to Zydus Cadila’s market share.

9. Alkem Laboratories Ltd.
Alkem Laboratories Ltd. is a reputable pharmaceutical company in India, known for its high-quality generic medications. The company’s Levetiracetam generics have been well-received in the market, reflecting Alkem Laboratories’ focus on customer satisfaction.

10. Mankind Pharma Ltd.
Mankind Pharma Ltd. is a growing player in the Indian pharmaceutical industry, with a focus on affordable generic medications. The company’s Levetiracetam generics have been gaining market share, reflecting Mankind Pharma’s commitment to providing cost-effective treatment options.

Insights:

The market for Levetiracetam generics in India is expected to continue growing in the coming years, driven by the increasing prevalence of epilepsy and the demand for affordable medications. According to recent forecasts, the production volume of Levetiracetam generics in India is projected to rise significantly, indicating a promising outlook for the industry. As more companies enter the market and competition intensifies, it will be crucial for manufacturers to differentiate themselves through quality, innovation, and pricing strategies to maintain a competitive edge. Overall, the future looks bright for the top Levetiracetam generic manufacturers in India, with ample opportunities for growth and success in the evolving pharmaceutical landscape.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →